Docetaxel, Taxotere (Anhydrous)
-
Molecular Structure
Detailed Description
1). Docetaxel, Taxotere (Anhydrous) 114977-28-5
Catelog: APIs; pharmaceutical chemicals; Semi synthetic anti cancer agent.
Product Name: Docetaxel anhydrous
Quality Standard: USP33
CAS NO.:114977-28-5 (Anhydrous)
Formular: C43H53NO14 (807.89)
Assay (by HPLC calculated on anhydrous
Solvent free basis):98.0%~102%
Source: Semi-synthesis from 10-DAB
Package: 200g/tin, 100g/tin, 10g/ foil bag
Place of origin: wuhan china (main land)
Indication: For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer.